Latest news
Datroway Wins EU Approval for First-Line Metastatic Triple-Negative Breast Cancer - BioPharm InternationalBioPharm International · Fri, 31 Jul 2026 17:17:31 GMTDatroway joins Trodelvy for frontline TNBC in the EU - pharmaphorumpharmaphorum · Fri, 31 Jul 2026 11:40:49 GMTEuropean Commission Approves First-Line Dato-DXd for Immunotherapy-Ineligible Metastatic TNBC - OncLiveOncLive · Fri, 31 Jul 2026 10:24:43 GMT